Risk-Adapted and MRD-Driven Strategy
1 clinical trials · Condition
◉ Watch Risk-Adapted and MRD-Driven Strategy
| Record | Firm | Date |
|---|---|---|
| Evaluation of Risk-Adapted and MRD-Driven Strategy for Untreated Fit Patients With Intermediate Risk Chronic Lymphocytic Leukemia (NCT04010968) | French Innovative Leukemia Organisation | 2019-09-27 |
Track Risk-Adapted and MRD-Driven Strategy automatically
Every clearance here is in the API, with alerts when new ones post.